CURRENT
ISSUE
1565
February 11, 2019
Cholesterol management guidelines from the American
College of Cardiology/American Heart Association Task
Force have recently been published. See Table 1 for a
brief summary of their recommendations.... Continue reading
More from Issue 1565
Previous Issue: 1564 January 28, 2019
- OTC Primatene Mist Returns
- Qbrexza - A Glycopyrronium Cloth for Axillary Hyperhidrosis
- Plenvu - A Low-Volume PEG-Based Colonoscopy Preparation
- Revefenacin (Yupelri) for COPD
- Aripiprazole with Digital Ingestion Tracking (Abilify MyCite)
Coming Soon
Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes
Drug Interaction: Opioids and Oral P2Y12 Platelet Inhibitors
Elderberry for Influenza
Oxybutynin for Hot Flashes in Women with Breast Cancer
Drugs for Gout
Subscribe
Tweets
ADVANCE
RELEASE
RELEASE
The FDA has approved a manually injected, single-dose, prefilled epinephrine syringe (Symjepi – Adamis/Sandoz) for emergency treatment of anaphylaxis. The new device is approved in 0.3- and 0.15-mg strengths for treatment of patients weighing ≥30 kg and 15 to 30 kg, respectively; only the 0.3-mg strength is currently available. According to Sandoz, Symjepi will be made available first to institutions and later to the retail market.
EPINEPHRINE ...
